Abstract
Systemic autoimmune diseases (SAD) can be defined as inflammatory diseases with an immune mechanism, of unknown etiology, involving at least 2 organs or systems. This category includes collagen-vascular diseases, vasculitides, granulomatous diseases, while excluding systemic inflammatory diseases with known causes. Cardiovascular changes are among the most frequent causes of morbi-mortality in patients with SAD by many mechanisms, including sustained systemic inflammation. Chronic right ventricular (RV) involvement in SAD may be due to long-term left ventricular (LV) decompensation, inflammation and myocardial fibrosis generated by the disease itself, pulmonary parenchymal changes and/or pulmonary hypertension (PAH), chronic repetitive pulmonary embolism. These differ in type, prevalence, intensity between the various forms of SAD. Systemic sclerosis (SSc) is the most frequent disease that causes lung and cardiac involvement. SS generates PAH by multiple mechanisms mainly in the cutaneous form, although it induces myocardial perfusion defects especially in the diffuse form. The RV involvement occurs earlier in SSc than in other forms of PAH and the prognosis is more severe. However, the new cardiac imaging techniques prove the occurrence of the systolic and diastolic dysfunction in right and left ventricles in cases without established PAH and clinical heart involvement. Systemic erythematosus lupus (SLE), mixed connective-tissue disease (MCTD), Sjogren syndrome (SjS), rheumatoid arthritis (RA) determine less often PAH and RV involvement. There are also other mechanisms for the cardiac involvement in SAD, like coronaritis, accelerated atherosclerosis or pericarditis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J. 2007;28(15):1797–804.
Luqmani RA, Suppiah R, Grayson PC, Merkel PA, Watts R. Nomenclature and classification of vasculitis—update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS). Clin Exp Immunol. 2011;164(Suppl 1):11–3.
Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risc: lessons from rheumatoid arthritis. Eur Heart J. 2017;38(22):1717–27.
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50.
Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23–68.
Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112(22):3337–47.
Cosgrove GP, Schwarz MI. Pulmonary manifestations of the collagen vascular diseases. https://thoracickey.com/pulmonarymanifestationsofthecollagenvasculardiseases/.
Capobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GSP. Thoracic manifestations of collagen vascular diseases. Radio Graphics. 2012;32(1):33–50.
Cosgrove GP, Schwarz MI. Pulmonary manifestations of the collagen vascular diseases, chapter 60, p 902–918. In: Fishman’ s pulmonary diseases and disorders. 15th ed. New York: McGraw-Hill; 2015.
Noordegraaf AV, Westerhof BE, Westerhof N. The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol. 2017;69(2):236–43.
Naejije R, Brimioulle S, Dewachter L. Biomechanics of the right ventricle in health and disease (2013 Grover conference series). Pulm Circ. 2014;4(3):395–406.
Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62(suppl 25):D22–33.
Condliffe R, Howard LS. Connective tissue disease-associated pulmonary arterial hypertension. F1000Prime Rep. 2015;7:06. https://doi.org/10.12703/P7-06.
D’Andrea A, Stisi S, Bellissimo S, Vigorito F, di Uccio FS, Tozzi N, et al. Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiography. 2005;6(6):407–18.
Hassoun PM. The right ventricle in scleroderma (2013 Grover conference series). Pulm Circ. 2015;5(1):3–14.
Overbeek MJ, Mouchaers KTB, Niessen HM, Hadi AM, Kupreishvili K, Boonstra A, et al. Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension. Int J Rheumatol. 2010:604615. https://doi.org/10.1155/2010/604615.
Vonk MC, Sande MH, van den Hoogen FHJ, van Riel PLCM, Verheugt FWA, van Dijk APJ. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr. 2007;8(5):317–21.
Kepez A, Akdogan A, Sade LE, Deniz A, Kalyoncu U, Karadag O, Hayran M, Aytemir K, Ertenli I, Kiraz S, Calguneri M, Kabakci G, Tokgozoglu L. Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography. 2008;25(2):191–7.
Pigatto E, Peluso D, Zanatta E, Polito P, Miatton P, Bourji K, et al. Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients. Reumatismo. 2014;66(4):259–63.
Loureiro MJ, Cotrim C, Simoes O, Cordeiro A, Santos MJ, Silva C, et al. Exercise Doppler echocardiography in the detection of pulmonary arterial hypertension in collagen vascular disease, P 1139, European congress of echocardiography. Eur J of Echocardiogr. 2005;6(suppl 1):S184–5.
Giunta A, Tirri E, Maione S, Cangianiello S, Mele A, DeLuca A, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis. 2000;59(2):94–8.
Rosato E, Maione S, Vitarelli A, Giunta A, Fontanella L, de Horatio LT, et al. Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables. Rheumatol Int. 2009;29(8):913–9.
Nakajima K, Taki J, Kawano M, Higuchi T, Sato S, Nishijima C, et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. J Nucl Med. 2001;42(2):183–8.
Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging. 2009;24(4):299–309.
Lang R, Goldstein SA, Kronzon I, Khandheria BK, Mor-Avi V. ASE’s comprehensive echocardiography. 2nd ed. Amsterdam: Elsevier; 2016.
Poorzand H, Mirfeizi SZ, Javanbakht A, Alimi H. Comparison of echocardiographic variables between systemic lupus erythematosus patients and a control group. Arch Cardiovasc Imaging. 2015;3(2):e30009. https://doi.org/10.5812/acvi.30009.
Elnady BM, Abdelghafar ASM, Khalik ESA, Algethami MM, Basiony AS, Al-otaibi MDA, et al. The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients. Eur J Rheumatol. 2016;3(3):109–17. https://doi.org/10.5152/eurjrheum.2016.16002.
Tektonidou MG, Ioannidis JP, Moyssakis I, Boki KA, Vassiliou V, Vlachoyiannopoulos PG, et al. Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome. Ann Rheum Dis. 2001;60(1):43–8.
Leal GN, Silva KF, Franca CM, Lianza AC, Andrade JL, Campos LM, et al. Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography. Lupus. 2015;24(6):613–20.
Vég J, Hegedűs I, Szegedi G, Zeher M, Bodolay E. Diastolic function of the heart in mixed connective tissue disease. Clin Rheumatol. 2007;26(2):176–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Nanea, I.T., Gheorghe, G.S. (2018). Right Ventricular Function in Systemic Autoimmune Diseases. In: Dumitrescu, S., Ţintoiu, I., Underwood, M. (eds) Right Heart Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-73764-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-73764-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73763-8
Online ISBN: 978-3-319-73764-5
eBook Packages: MedicineMedicine (R0)